Skip to main content
Trending this week: Beyond RTRt Models: The Hidden Challenges of Implementation https://bit.ly/3ycJ82P
3.147.42.163

Tags: Review article

All Categories (1-25 of 106)

  1. Using residence time distribution in pharmaceutical solid dose manufacturing–A critical review

    Contributor(s):: Bhalode, Pooja, Tian, Huayu Gupta, Shashwat Razavi, Sonia M Roman-Ospino, Andres Talebian, Shahrzad Singh, Ravendra Scicolone, James V Muzzio, Fernando J, Ierapetritou, Marianthi

    While continuous manufacturing (CM) of pharmaceutical solid-based drug products has been shown to be advantageous for improving the product quality and process efficiency in alignment with FDA’s support of the quality-by-design paradigm (Lee, 2015; Ierapetritou et al., 2016; Plumb, 2005; Schaber,...

  2. Twin screw granulation - review of current progress

    Contributor(s):: Thompson, M. R.

    Twin screw granulation (TSG) is a new process of interest to the pharmaceutical community that can continuously wet granulate powders, doing so at lower liquid concentrations and with better product consistency than found by a high shear batch mixer. A considerable body of Research Article has...

  3. Twin-screw melt granulation: Current progress and challenges

    Contributor(s):: Kittikunakorn, Nada, Liu, Tongzhou, Zhang, Feng

    Twin-screw melt granulation (TSMG) is a new alternative method for granulation that offers several advantages over wet and dry granulation methods. TSMG has rapidly gained interest over recent years in the pharmaceutical industry. Since it is an inherently continuous process with controlled...

  4. Towards 4th industrial revolution efficient and sustainable continuous flow manufacturing of active pharmaceutical ingredients

    Contributor(s):: Sagandira, CR, Nqeketo, SMhlana, K, Sonti, T, Gaqa, S, Watts, P

    Continuous flow chemistry has opened a new paradigm in both the laboratory and pharmaceutical industry. This review details the recently reported literature on continuous multistep telescoped synthesis of active pharmaceutical ingredients (APIs), inline flow downstream processing, in-process...

  5. Towards a Greener Pharmacy by More Eco Design

    Contributor(s):: Baron, M

    This review proposes an overview of the main trends explored by the pharmaceutical industry in order to develop a greener and smarter pharmacy minimizing any negative impact to the environment, and using more sustainable processes and drugs. If many drugs have their origin in nature, many active...

  6. The reality of in-line tablet coating

    Contributor(s):: Cahyadi, Christine, Chan, Lai Wah, Heng, Paul Wan Sia

    The possibility of continuous processing in pharmaceutical tablet manufacturing is hampered by the viscoelastic recovery of tablets post-compaction. Compacted tablets are typically aged before coating to allow complete viscoelastic recovery so as to avoid subsequent coating defects. There has...

  7. The Future of Pharmaceutical Manufacturing Sciences

    Contributor(s):: Rantanen, Jukka, Khinast Johannes

    The entire pharmaceutical sector is in an urgent need of both innovative technological solutions and fundamental scientific work, enabling the production of highly engineered drug products. Commercial-scale manufacturing of complex drug delivery systems (DDSs) using the existing technologies is...

  8. Template-induced nucleation for controlling crystal polymorphism: from molecular mechanisms to applications in pharmaceutical processing

    Contributor(s):: Parambil, JV, Poornachary, SKHeng, JYY, Tan, RBH

    Over the last two decades, the use of template surfaces to induce heterogeneous crystal nucleation has been explored primarily to address two different goals: first, as an alternative to the conventional seeding technique used for polymorph control and, second, as a technique to promote the...

  9. The Changing Face of Process Development & Chemical Manufacturing - A View from the Regulators on Continuous Manufacturing

    Contributor(s):: Wiles, Charolotte

    Industry wide there is a drive for resource efficiency and flexibility, to adapt quickly in what is increasingly becoming a volatile, changing marketplace. As the ‘patent cliff’ looms for many high-volume API’s, there is also a shift away from blockbusters towards lower volume, higher potency...

  10. The Concept of Chemical Generators: On-Site On-Demand Production of Hazardous Reagents in Continuous Flow

    Contributor(s):: Dallinger, D, Gutmann, B, Kappe, CO

    CONSPECTUS: In recent years, a steadily growing number of chemists, from both academia and industry, have dedicated their Research Article to the development of continuous flow processes performed in milli- or microreactors. The common availability of continuous flow equipment at virtually all...

  11. Solid forms of pharmaceuticals: Polymorphs, salts and cocrystals

    Contributor(s):: Sarma, B, Chen, JHsi, HY, Myerson, AS

    Control and selection of the properties of active pharmaceutical ingredients is a crucial part of the drug development process. One major part of this process is the selection of an appropriate solid form. This review will discuss three major types of crystalline solids, polymorphs, salts and...

  12. Separation and Purification in the Continuous Synthesis of Fine Chemicals and Pharmaceuticals

    Contributor(s):: O'Mahony, M, Ferguson, SStelzer, T, Myerson, A

    The use to both chemists and chemical engineers working in flow synthesis, this chapter provides a summary of separation and purification operations that can be applied to flow synthesis reaction streams. Both single and biphasic separations for the liquid phase are detailed. Separation and...

  13. Simulated moving bed chromatography for the separation of enantiomers

    Contributor(s):: Rajendran, A, Paredes, G, Mazzotti, M

    Simulated moving bed (SMB) chromatography, a continuous multi-column chromatographic process, has become one of the preferred techniques for the separation of the enantiomers of a chiral compound. Several active pharmaceutical ingredients, including blockbuster drugs, are manufactured using the...

  14. Sampling and Analysis in Flow: The Keys to Smarter, More Controllable, and sustainable Fine-Chemical Manufacturing

    Contributor(s):: Morin, Mathieu, Zhang, Wenyao, Mallik, Debasis, Organ, Michael G

    Process analytical technology (PAT) is a system designed to help chemists better understand and control manufacturing processes. PAT systems operate through the combination of analytical devices, reactor control elements, and mathematical models to ensure the quality of the final product through...

  15. Scaling continuous API synthesis from milligram to kilogram: extending the enabling benefits of micro to the plant

    Contributor(s):: Berton, M, de, Souza, JMAbdiaj, I, McQuade, DT, Snead, DR

    The signature benefits of continuous flow are largely a result of a reactor's micro-sized features. However, as the technology gains industrial traction in the synthesis of active pharmaceutical ingredients (API), the reactors must be scaled to larger size to meet production demands. Often, the...

  16. Review: Continuous Manufacturing of Small Molecule Solid Oral Dosage Forms

    Contributor(s):: Wahlich, John

    Continuous manufacturing (CM) is defined as a process in which the input material(s) are continuously fed into and transformed, and the processed output materials are continuously removed from the system. CM can be considered as matching the FDA’s so-called ‘Desired State’ of pharmaceutical...

  17. Recent advances in integrated process analytical techniques, modeling, and control strategies to enable continuous biomanufacturing of monoclonal antibodies

    Contributor(s):: Chopda, Viki, Gyorgypal, Aron Yang, Ou Singh, Ravendra Ramachandran, Rohit Zhang, Haoran Tsilomelekis, George Chundawat, Shishir PS, Ierapetritou, Marianthi G

    Continuous bioprocessing is significantly changing the biological drugs (or biologics) manufacturing landscape by potentially improving product quality, process stability, and overall profitability, as was similarly seen during the adoption of advanced manufacturing processes for small molecule...

  18. Recent Developments in the Crystallization Process: Toward the Pharmaceutical Industry

    Contributor(s):: Gao, Zhenguo, Gong, Junbo, Rohani, Sohrab, Wang, Jingkang

    Crystallization is one of the oldest separation and purification unit operations, and has recently contributed to significant improvements in producing higher-value products with specific properties and in building efficient manufacturing processes. In this paper, we review recent developments in...

  19. Recent progress in continuous and semi-continuous processing of solid oral dosage forms: a review

    Contributor(s):: Tezyk, Michal, Ernst, Andrzej, Milanowski, Bartlomiej, Lulek, Janina

    Continuous processing is an innovative production concept well known and successfully used in other industries for many years. The modern pharmaceutical industry is facing the challenge of transition from a traditional manufacturing approach based on batch-wise production to a continuous...

  20. Recent Progress in Continuous Crystallization of Pharmaceutical Products: Precise Preparation and Control

    Contributor(s):: Ma, Yiming, Joao Macaringue, Estevao, Zhang, Teng, Gong, Junbo, Wu, Songgu, Wang, Jingkang

    Crystallization, as a solid−liquid separation process, is employed to purify and isolate a great diversity of crystalline pharmaceutical products. In recent years, continuous crystallization has attracted increasing attention because of the product and process robustness as well as higher...

  21. Recent progress in continuous manufacturing of oral solid dosage forms

    Contributor(s):: Vanhoorne, Valérie, Vervaet, Chris

    Continuous drug product manufacturing is slowly being implemented in the pharmaceutical industry. Although the benefits related to the quality and cost of continuous manufacturing are widely recognized, several challenges hampered the widespread introduction of continuous manufacturing of drug...

  22. Raman spectroscopy as a process analytical technology for pharmaceutical manufacturing and bioprocessing

    Contributor(s):: Esmonde-White, Karen A, Cuellar, Maryann, Uerpmann, Carsten, Lenain, Bruno., Lewis, Ian R.

    Adoption of Quality by Design (QbD) principles, regulatory support of QbD, process analytical technology (PAT), and continuous manufacturing are major factors effecting new approaches to pharmaceutical manufacturing and bioprocessing. In this review, we highlight new technology developments, data...

  23. Raman Spectroscopy for Process Analytical Technologies of Pharmaceutical Secondary Manufacturing

    Contributor(s):: Nagy, Brigitta, Farkas, Attila, Borbás, Enikő, Vass, Panna, Nagy, Zsombor Kristóf, Marosi, György

    As the process analytical technology (PAT) mindset is progressively introduced and adopted by the pharmaceutical companies, there is an increasing demand for effective and versatile real-time analyzers to address the quality assurance challenges of drug manufacturing. In the last decades, Raman...

  24. Reactor design and selection for effective continuous manufacturing of pharmaceuticals

    Contributor(s):: Hu, Chuntian

    Pharmaceutical production remains one of the last industries that predominantly uses batch processes, which are inefficient and can cause drug shortages due to the long lead times or quality defects. Consequently, pharmaceutical companies are transitioning away from outdated batch lines, in large...

  25. Real-time feasible model-based crystal size and shape control of crystallization processes

    Contributor(s):: Szilagyi, Botond, Nagy, Zoltan K.

    The simultaneous control of crystal size and shape is particularly important in fine chemical and pharmaceutical crystallization. These two quantities influence the dissolution rate and bioavailability of final drug products, and also contribute to the manufacturability and efficiency of...